We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+12.1%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.2B
AUM Growth
+$4.2B
Cap. Flow
+$540M
Cap. Flow %
12.85%
Top 10 Hldgs %
18.08%
Holding
299
New
56
Increased
119
Reduced
60
Closed
32

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$49.4M
2
V icon
Visa
V
+$40.6M
3
ABBV icon
AbbVie
ABBV
+$26.7M
4
AON icon
Aon
AON
+$23.6M
5
C icon
Citigroup
C
+$19.9M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$27.6M
2
CSCO icon
Cisco
CSCO
+$15.5M
3
MCK icon
McKesson
MCK
+$11.4M
4
MU icon
Micron Technology
MU
+$10.7M
5
FLS icon
Flowserve
FLS
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 24.38%
2 Financials 22.67%
3 Healthcare 20.31%
4 Communication Services 9.26%
5 Consumer Discretionary 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENOC
226
DELISTED
EnerNOC, Inc.
ENOC
$1.17M 0.03%
68,098
-258,261
-79% -$4.26M
HDB icon
227
HDFC Bank
HDB
$122B
$1.17M 0.03%
135,600
– –
HCSG icon
228
Healthcare Services Group
HCSG
$1.62B
$1.09M 0.03%
38,372
– –
VIVO
229
DELISTED
Meridian Bioscience Inc
VIVO
$1.06M 0.03%
40,000
– –
LDRH
230
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$1.01M 0.02%
+42,857
New +$959K
EVOL
231
DELISTED
Evolving Systems, Inc.
EVOL
$665K 0.02%
+69,000
New +$697K
NFLX icon
232
Netflix
NFLX
$302B
$562K 0.01%
106,890
-60,340
-36% -$296K
ALR
233
DELISTED
AlerisLife Inc
ALR
$516K 0.01%
9,410
-15,480
-62% -$784K
CELG
234
DELISTED
Celgene Corp
CELG
$422K 0.01%
+4,990
New +$395K
EXAR
235
DELISTED
Exar Corporation
EXAR
$414K 0.01%
35,116
-205,834
-85% -$2.54M
MET icon
236
MetLife
MET
$62.7B
$403K 0.01%
8,393
+1,459
+21% +$65.4K
ITUB icon
237
Itaú Unibanco
ITUB
$92B
$380K 0.01%
76,828
+44,231
+136% +$230K
BIIB icon
238
Biogen
BIIB
$30.4B
$379K 0.01%
+1,353
New +$350K
DOC icon
239
Healthpeak Properties
DOC
$15.8B
$363K 0.01%
10,980
– –
TCBI icon
240
Texas Capital Bancshares
TCBI
$4.3B
$337K 0.01%
5,420
-1,250
-19% -$66.6K
AMGN icon
241
Amgen
AMGN
$212B
$317K 0.01%
+2,781
New +$316K
SWH
242
DELISTED
Stanley Black & Decker, Inc.
SWH
$309K 0.01%
+3,000
New +$308K
PB icon
243
Prosperity Bancshares
PB
$8.81B
$296K 0.01%
4,671
-3,665
-44% -$231K
TLRA
244
DELISTED
Telaria, Inc.
TLRA
$185K ﹤0.01%
+31,929
New +$222K
MM
245
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$161K ﹤0.01%
22,158
– –
AVNR
246
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$60K ﹤0.01%
+17,821
New +$73.6K
OREX
247
DELISTED
Orexigen Therapeutics, Inc.
OREX
$58K ﹤0.01%
+1,031
New +$57.9K
ACHN
248
DELISTED
Achillion Pharmaceuticals
ACHN
$50K ﹤0.01%
+15,121
New +$43.9K
ALGN icon
249
Align Technology
ALGN
$12.4B
– –
-316,773
Closed -$15.2K
BAP icon
250
Credicorp
BAP
$31B
– –
-3,533
Closed -$437
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Polar Capital held 299 positions worth $4.2B, up 112,182% from $3.74M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Polar Capital deployed $540M of net new capital in Q4 2013, opening 56 new positions and adding to 119 existing holdings. Its largest new stake was Pediatrix Medical: 330,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Mastercard, an estimated $27.6M trimmed.

  • Polar Capital's largest Q4 2013 buy was Pediatrix Medical: 330,000 shares worth $17.6M.
  • Polar Capital added most to Apple in Q4 2013, an estimated $49.4M increase.
  • Polar Capital's biggest Q4 2013 reduction was Mastercard, cutting an estimated $27.6M.
  • Polar Capital fully exited Brunswick in Q4 2013, selling an estimated $18.3K.
  • Polar Capital's ten largest holdings make up 18% of its $4.2B portfolio in Q4 2013.
  • Polar Capital opened 56 new positions and closed 32 in Q4 2013.
  • Polar Capital's portfolio value rose 112,182% quarter-over-quarter to $4.2B.

Based on Polar Capital's 13F filing for Q4 2013, filed 11 Feb 2014.